Pharmacologic Anticoagulation is Associated with a Lower Risk of Recurrent Venous Thromboembolic Events During Janus Kinase Inhibitor Use for Patients with a Prior Thrombosis.
Inflammatory Bowel Diseases（2024）
Key words
Janus kinase inhibitor,venous thromboembolism,tofacitinib,upadacitinib,anticoagulation
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined